Group One Trading’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-186,355
Closed -$157K 7895
2023
Q4
$198K Buy
+186,355
New +$202K ﹤0.01% 3873
2022
Q1
Sell
-5,578
Closed -$32.6K 8649
2021
Q4
$31K Buy
5,578
+5,528
+11,056% +$41.8K ﹤0.01% 6708
2021
Q3
$0 Buy
+50
New +$464 ﹤0.01% 8738
2021
Q2
Sell
-27,237
Closed -$266K 8542
2021
Q1
$233K Buy
27,237
+27,235
+1,361,750% +$223K ﹤0.01% 4872
2020
Q4
$0 Hold
2
﹤0.01% 6956
2020
Q3
$0 Hold
2
﹤0.01% 6510
2020
Q2
$0 Hold
2
﹤0.01% 6140
2020
Q1
$0 Hold
2
﹤0.01% 5702
2019
Q4
$0 Sell
2
-1
-33% -$5 ﹤0.01% 5572
2019
Q3
$0 Hold
3
﹤0.01% 5508
2019
Q2
$0 Hold
3
﹤0.01% 5352
2019
Q1
$0 Sell
3
-1
-25% -$70 ﹤0.01% 5323
2018
Q4
$0 Hold
4
﹤0.01% 5366
2018
Q3
$0 Hold
4
﹤0.01% 5573
2018
Q2
$1K Hold
4
﹤0.01% 4999
2018
Q1
$1K Buy
+4
New +$1.14K ﹤0.01% 4710
2017
Q1
Sell
-2
Closed -$3.31K 4969
2016
Q4
$6K Buy
+2
New +$11.6K ﹤0.01% 4072

Other funds holding SLS

Group One Trading's SLS Position: Q1 2024 in Review

Group One Trading sold out of SELLAS Life Sciences (SLS) in Q1 2024, closing a stake of 186,355 shares — an estimated $157K sold.

Group One Trading first reported a position in SLS in Q4 2016 and held it in 17 quarters. The position peaked at $233K in Q1 2021. 30 funds tracked by Wall St. Rank hold SLS as of Q1 2024.

  • Group One Trading reported no remaining SELLAS Life Sciences position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 186,355 SELLAS Life Sciences shares in Q1 2024, an estimated $157K.
  • Group One Trading first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 17 quarters.
  • Group One Trading's SELLAS Life Sciences position peaked at $233K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.